ESR1 and breast carcinoma: Furthermore, Ryan et al. (2016) established a set of biomarker genes capable of predicting activation of the estrogen receptor α (ERα) using breast cancer-derived cell line MCF-7, which is perturbed by endocrine disrupting chemicals [14].